ATE281647T1 - Verfahren zur typisierung von hepatitis c viren und dafür zu verwendende reagenzien - Google Patents

Verfahren zur typisierung von hepatitis c viren und dafür zu verwendende reagenzien

Info

Publication number
ATE281647T1
ATE281647T1 AT94916061T AT94916061T ATE281647T1 AT E281647 T1 ATE281647 T1 AT E281647T1 AT 94916061 T AT94916061 T AT 94916061T AT 94916061 T AT94916061 T AT 94916061T AT E281647 T1 ATE281647 T1 AT E281647T1
Authority
AT
Austria
Prior art keywords
viruses
reagents
used therefor
type
typing
Prior art date
Application number
AT94916061T
Other languages
English (en)
Inventor
David Y Chien
George Kuo
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22029220&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE281647(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of ATE281647T1 publication Critical patent/ATE281647T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT94916061T 1993-05-10 1994-05-09 Verfahren zur typisierung von hepatitis c viren und dafür zu verwendende reagenzien ATE281647T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6040093A 1993-05-10 1993-05-10
PCT/US1994/005151 WO1994027153A1 (en) 1993-05-10 1994-05-09 Methods of typing hepatitis c virus and reagents for use therein

Publications (1)

Publication Number Publication Date
ATE281647T1 true ATE281647T1 (de) 2004-11-15

Family

ID=22029220

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94916061T ATE281647T1 (de) 1993-05-10 1994-05-09 Verfahren zur typisierung von hepatitis c viren und dafür zu verwendende reagenzien

Country Status (19)

Country Link
US (3) US6054264A (de)
EP (1) EP0698216B2 (de)
JP (1) JP3645904B2 (de)
KR (1) KR100330278B1 (de)
CN (1) CN1129795C (de)
AT (1) ATE281647T1 (de)
CZ (1) CZ294629B6 (de)
DE (1) DE69434117T3 (de)
DK (1) DK0698216T4 (de)
ES (1) ES2232815T5 (de)
GE (1) GEP20012421B (de)
HU (1) HU224513B1 (de)
PL (3) PL175360B1 (de)
PT (1) PT698216E (de)
RO (1) RO115471B1 (de)
RU (1) RU2158928C2 (de)
SK (1) SK282543B6 (de)
UA (1) UA46707C2 (de)
WO (1) WO1994027153A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0610436B9 (de) 1991-11-21 2003-03-26 Common Services Agency Detektion des Hepatis-C Virus.
US7255997B1 (en) * 1993-04-27 2007-08-14 N.V. Innogenetics S.A. Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
EP0984068B1 (de) 1993-04-27 2012-03-28 Innogenetics N.V. Sequenzen von Hepatitis C Virus-Genotypen sowie ihre Verwendungen als Therapeutika und Diagnostika
DK0698216T4 (da) * 1993-05-10 2009-06-15 Novartis Vaccines & Diagnostic Fremgangsmåder til typebestemmelse af hepatitis-C-virus og anvendte reagenser heri
US5882852A (en) * 1993-06-29 1999-03-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Hepatitic C virus (HCV) core gene nucleotide sequences and related methods of detecting major and minor genotypes of HCV isolates
US7070790B1 (en) 1993-06-29 2006-07-04 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and deduced amino acid sequences of the envelope 1 and core genes of isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
DE19504302A1 (de) * 1995-02-09 1996-08-14 Boehringer Mannheim Gmbh Methode zur serologischen Typisierung mittels typspezifischer Antigene
WO1996034013A1 (en) * 1995-04-28 1996-10-31 Srl, Inc. Antigen peptide compound and immunoassay method
US6514731B1 (en) 1996-05-24 2003-02-04 Chiron Corporation Methods for the preparation of hepatitis C virus multiple copy epitope fusion antigens
RU2146825C1 (ru) * 1998-05-07 2000-03-20 Харламова Флора Семеновна Способ диагностики внепеченочной персистенции вирусных антигенов в тканях у детей, больных хроническим гепатитом в, или дельта, или с
US7052830B1 (en) * 1998-06-09 2006-05-30 Branch Andrea D Hepatitis C virus peptides and uses thereof
WO2000031130A1 (en) * 1998-11-20 2000-06-02 Bio Merieux Synthetic polypeptides corresponding to the hepatitis c virus (hcv) and applications
US6995299B2 (en) * 1999-11-02 2006-02-07 University Of Connecticut Propagation of human hepatocytes in non-human animals
US8124348B2 (en) * 2000-08-23 2012-02-28 Jonathan Zmuda Oral fluid rapid assay for hepatitis C virus (HCV) antibodies using non-antibody labeling of IgA molecules recognizing HCV peptide epitopes
WO2002090572A2 (en) * 2001-05-09 2002-11-14 Third Wave Technologies, Inc. Nucleic acid detection in pooled samples
US7196183B2 (en) * 2001-08-31 2007-03-27 Innogenetics N.V. Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
WO2003085375A2 (en) * 2002-04-04 2003-10-16 Achillion Pharmaceuticals, Inc. Hcv antiviral and cytotoxicity drug screening assay
WO2005010035A2 (en) * 2003-07-22 2005-02-03 Branch Andrea D Alternate reading frame polypeptides derived from hepatitis c and methods of their use
US20050075309A1 (en) 2003-07-25 2005-04-07 Richard Storer Purine nucleoside analogues for treating Flaviviridae including hepatitis C
US8124747B2 (en) * 2003-08-29 2012-02-28 Innogenetics HCV clade and prototype sequences thereof
RU2269134C2 (ru) * 2003-11-27 2006-01-27 Санкт-Петербургский научно-исследовательский институт эпидемиологии и микробиологии имени Пастера Способ прогнозирования исходов острого вирусного гепатита с
CA2552949C (en) 2004-01-07 2012-10-02 Third Wave Technologies, Inc. Determination of hepatitis c virus genotype
JP4533656B2 (ja) * 2004-04-28 2010-09-01 アボットジャパン株式会社 特異性の改良されたｃ型肝炎ウイルス（ｈｃｖ）抗体測定法
US7858752B2 (en) * 2006-12-05 2010-12-28 Abbott Laboratories Recombinant antibodies against hepatitis C virus and methods of obtaining and using same
FR2984328B1 (fr) 2011-12-20 2016-12-30 Bio-Rad Innovations Procede de detection d'une infection par le virus de l'hepatite c
CN110261616B (zh) * 2019-04-30 2021-07-20 广东菲鹏生物有限公司 一种丙型肝炎病毒检测试剂盒

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868105A (en) * 1985-12-11 1989-09-19 Chiron Corporation Solution phase nucleic acid sandwich assay
US5124246A (en) * 1987-10-15 1992-06-23 Chiron Corporation Nucleic acid multimers and amplified nucleic acid hybridization assays using same
JPH02500880A (ja) * 1987-11-18 1990-03-29 カイロン　コーポレイション Ｎａｎｂｖの診断用薬およびワクチン
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
KR0185373B1 (ko) * 1989-03-17 1999-05-01 로버트 피. 블랙버언 Hcv 폴리단백질에서 유래되는 hcv 아미노산 서열 부분을 포함하는 폴리펩티드 및 그 사용
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV
HU217025B (hu) * 1990-04-04 1999-11-29 Chiron Corp. Hepatitis C vírus-(HCV) antigénkészítmények az anti-HCV-antitestek kimutatására immunoassay-kben
US6190864B1 (en) * 1991-05-08 2001-02-20 Chiron Corporation HCV genomic sequences for diagnostics and therapeutics
ES2188583T3 (es) * 1991-06-24 2003-07-01 Chiron Corp Polipeptidos para el virus de la hepatitis c (hcv).
ES2111589T3 (es) * 1991-08-27 1998-03-16 Hoffmann La Roche Metodos y reactivos para la deteccion de la hepatitis c.
EP0532258A2 (de) * 1991-09-09 1993-03-17 Immuno Japan Inc. Oligonukleotide und Verfahren zum Nachweis von HCV-Gentypen
AU2679492A (en) * 1991-09-16 1993-04-27 Abbott Laboratories Hepatitis c assay
EP0610436B9 (de) * 1991-11-21 2003-03-26 Common Services Agency Detektion des Hepatis-C Virus.
KR100317509B1 (ko) 1992-07-16 2002-02-20 야스모토 토루 C형간염바이러스를분류하기위한항원성펩티드,이펩티드를포함하는키트및이펩티드를사용하는c형간염바이러스를분류하는방법
AU680450B2 (en) * 1992-11-06 1997-07-31 Mimotopes Pty Ltd Support for the synthesis of modular polymers
EP0698101B1 (de) 1993-05-05 2004-11-03 Common Services Agency Hepatitis-c virus typ 4,5 und 6
DK0698216T4 (da) * 1993-05-10 2009-06-15 Novartis Vaccines & Diagnostic Fremgangsmåder til typebestemmelse af hepatitis-C-virus og anvendte reagenser heri
WO1995011918A1 (en) * 1993-10-29 1995-05-04 Srl, Inc. Antigen peptide compound and immunoassay method

Also Published As

Publication number Publication date
DE69434117D1 (de) 2005-01-20
PT698216E (pt) 2005-03-31
RO115471B1 (ro) 2000-02-28
KR100330278B1 (ko) 2002-08-19
RU2158928C2 (ru) 2000-11-10
EP0698216B2 (de) 2009-02-25
EP0698216B1 (de) 2004-11-03
JPH08510329A (ja) 1996-10-29
CZ292995A3 (en) 1996-05-15
PL175360B1 (pl) 1998-12-31
ES2232815T3 (es) 2005-06-01
WO1994027153A1 (en) 1994-11-24
US6416946B1 (en) 2002-07-09
UA46707C2 (uk) 2002-06-17
CN1125982A (zh) 1996-07-03
SK135995A3 (en) 1996-09-04
HU9503219D0 (en) 1996-01-29
GEP20012421B (en) 2001-04-25
DE69434117T2 (de) 2006-02-02
PL311653A1 (en) 1996-03-04
PL175342B1 (pl) 1998-12-31
DK0698216T4 (da) 2009-06-15
JP3645904B2 (ja) 2005-05-11
DE69434117T3 (de) 2009-10-08
CN1129795C (zh) 2003-12-03
CZ294629B6 (cs) 2005-02-16
SK282543B6 (sk) 2002-10-08
HUT73384A (en) 1996-07-29
PL175338B1 (pl) 1998-12-31
DK0698216T3 (da) 2005-02-14
HU224513B1 (hu) 2005-10-28
US6416944B1 (en) 2002-07-09
ES2232815T5 (es) 2009-06-15
EP0698216A1 (de) 1996-02-28
US6054264A (en) 2000-04-25

Similar Documents

Publication Publication Date Title
ATE281647T1 (de) Verfahren zur typisierung von hepatitis c viren und dafür zu verwendende reagenzien
ATE179459T1 (de) Verfahren zur typisierung von hcv-isolaten
DE68915202D1 (de) Verfahren zur Vermehrung und zum Nachweis von Nukleinsäuresequenzen.
DE68907407D1 (de) Verfahren zur sequenzanalyse von dna.
DE69839557D1 (de) Klonierte genome von infektiösen hepatitis c viren und deren verwendungen
DE69329108D1 (de) Verfahren zur inaktivierung von viren
ATE551423T1 (de) Sequenzen von hepatitis c virus-genotypen sowie ihre verwendungen als therapeutika und diagnostika
IT1278077B1 (it) Metodologia per riprodurre in vitro le attivita' di rna polimerasi rna-dipendente e di nucleotidiltransferasi terminale codificate dal
DK0644202T3 (da) Syntetiske antigener til påvisning af antistoffer imod hepatitis C virus
DE68916588D1 (de) Verfahren und Gerät zur Feststellung von Gasen.
DE3768833D1 (de) Verfahren zur herstellung von hcmv-glykoproteinen, antikoerper dagegen und hcmv-vakzine und dazu zu verwendende rekombinante vektoren.
ATE244729T1 (de) Verfahren zur identifizierung von wirkstoffen gegen hcv durch verwendung von strukturkoordinaten der hepatitis-c-virus- protease
DE69434688D1 (de) Diagnostischer nachweis von rna und reagentiensätze unter verwendung binärer rna proben und einer rna-abhängigen rna ligase
DE69018625D1 (de) Verfahren zum aufkonzentrieren von chlorgas.
DE59004059D1 (de) Verfahren zur Entfernung von Jod und Jodverbindungen aus wasserstoffhaltigen Gasen und Dämpfen.
DE69230917D1 (de) Verfahren zur detektion von hepatitis c
DE69111927D1 (de) Verfahren zur Entschwefelung von Abgasen.
DE69006489D1 (de) Verfahren zur kontinuierlichen wiedergewinnung von fluorwasserstoffgas.
ATE185377T1 (de) Genomische genkartierungsmethode durch direkten nachweis von haplotypen mittels intronsequenzanalyse
ATE270345T1 (de) Nukleinsaeure erkennung von hepatitis gb virus
DE69106141D1 (de) Non-a non-b sequenzen.
FI952778L (fi) Hepatiitti-C-viruksen (HCV) 3-ei-rakenne-peptidejä, vasta-aineita niitä vastaan ja menetelmiä HCV:n toteamiseksi
FI952779L (fi) HCV:n C33-alueen peptidejä, vasta-aineita niitä vastaan ja menetelmiä HCV:n toteamiseksi
DE69111637D1 (de) Verfahren zur Trennung und Konzentration von Phosphopeptiden.
ATE91156T1 (de) Verfahren zur sequenzanalyse von dna.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0698216

Country of ref document: EP

UEP Publication of translation of european patent specification

Ref document number: 0698216

Country of ref document: EP